3 July 2024
Freshfields advised Mars, Inc. on the acquisition of the Cerba HealthCare Group’s stake in Cerba Vet and Antagene
Advising firms
Deal team
18 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Guillemette Burgala Lead | Freshfields | Partner | Not stated | Not stated |
| Giles Pratt Lead | Freshfields | Partner | separation matters and commercial contracts | Not stated |
| Pascal Cuche Lead | Freshfields | Partner | regulatory aspects and foreign direct investment | Not stated |
| Alex Potter Lead | Freshfields | Partner | merger control aspects | Not stated |
| Paul Tiger Lead | Freshfields | Partner | US corporate advice | Not stated |
| Radu Valeanu | Freshfields | Counsel | Not stated | Not stated |
| Paul Bévierre | Freshfields | Counsel | Not stated | Not stated |
| Octavian David | Freshfields | Senior associate | Not stated | Not stated |
| Anne-Priscille Coulot | Freshfields | Associate | Not stated | Not stated |
| Naoufel Boudouda | Freshfields | Associate | Not stated | Not stated |
| Marine Valmont | Freshfields | Associate | Not stated | Not stated |
| Brieuc Trambouze | Freshfields | Associate | Not stated | Not stated |
| Zofia Aszendorf | Freshfields | Senior associate | separation matters and commercial contracts | Not stated |
| Tochukwu Egenti | Freshfields | Associate | separation matters and commercial contracts | Not stated |
| Tanguy Bardet | Freshfields | Counsel | regulatory aspects and foreign direct investment | Not stated |
| Léa Hirschi | Freshfields | Associate | regulatory aspects and foreign direct investment | Not stated |
| Sofia Bekkali | Freshfields | Counsel | merger control aspects | Not stated |
| Victor Ma | Freshfields | Associate | US corporate advice | Not stated |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Mars, Inc.Buy-side
- Counterparties
- Cerba HealthCare Group (Sell-side)